📰 Rick Eiswirth News
Rick Eiswirth News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Rick Eiswirth. Real-time updates on events, politics, business and more.
November 8, 2023
ATLANTA, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be...
October 27, 2023
Alimera Sciences, Inc. (NASDAQ:ALIM) Q3 2023 Earnings Call Transcript October 26, 2023 Alimera Sciences, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.41. Operator: Ladies and gentlemen, thank you for standing by. Good morning, and welcome to the Alimera Sciences Third Quarter 2022 [2023] (sic) Financial Results and Corporate Update Conference Call. [Operator […]
October 26, 2023
Record net revenue and significant decrease in net loss highlight the quarter
August 13, 2023
Alimera Sciences, Inc. (NASDAQ:ALIM) Q2 2023 Earnings Call Transcript August 10, 2023 Alimera Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.44 EPS, expectations were $0.06. Operator: Ladies and gentlemen, thank you for standing by. Good morning, and welcome to the Alimera Sciences Second Quarter 2023 Financial Results Conference Call. [Operator Instructions]. I would […]
May 18, 2023
By selling U.S. rights to Yutiq, EyePoint Pharmaceuticals gets $75 million cash to support its drug pipeline. The company’s lead product candidate is in mid-stage development for wet age-related macular degeneration and non-proliferative diabetic retinopathy.
May 15, 2023
Consolidated Net Revenue of $13.5 Million Up 14% vs. First Quarter of 2022Global End User Demand Up 14% vs. First Quarter of 2022 Financial Results and Corporate Update Conference Call Cancelled ... | May 15, 2023
April 4, 2023
Operator: Ladies and gentlemen, thank you for standing by. Good morning and welcome to the Alimera Sciences 2022 Financial Results Conference Call.
November 1, 2022
Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners
August 10, 2022
ATLANTA, Aug. 10, 2022 -- Alimera Sciences, Inc. , a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and... | August 10, 2022
July 30, 2022
Alimera Sciences, Inc. (NASDAQ:NASDAQ:ALIM) Q2 2022 Earnings Conference Call July 27, 2022 09:00 AM ET Company Participants Scott Gordon - CORE, Investor Relations Rick Eiswirth - President...